0.6490
0.0000
(0.00%)
At close: January 13 at 4:00:00 PM EST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | -0.24 | -0.25 | -1.23 | -0.8 |
| Low Estimate | -0.24 | -0.25 | -1.23 | -0.8 |
| High Estimate | -0.24 | -0.25 | -1.23 | -0.8 |
| Year Ago EPS | -0.51 | -0.07 | -0.98 | -1.23 |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | 1 |
| Avg. Estimate | 5.88M | 5.64M | 14.8M | 50.24M |
| Low Estimate | 5.88M | 5.64M | 14.8M | 50.24M |
| High Estimate | 5.88M | 5.64M | 14.8M | 50.24M |
| Year Ago Sales | 4.35M | 3.63M | 45.24M | 14.8M |
| Sales Growth (year/est) | 35.14% | 55.20% | -67.29% | 239.58% |
Earnings History
| Currency in USD | 12/31/2023 | 3/31/2024 | 6/30/2024 | 9/30/2024 |
|---|---|---|---|---|
| EPS Est. | -0.26 | -0.28 | -0.25 | -0.31 |
| EPS Actual | -0.51 | -0.07 | -0.33 | -0.35 |
| Difference | -0.25 | 0.21 | -0.09 | -0.04 |
| Surprise % | -96.15% | 75.00% | -34.69% | -12.90% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.24 | -0.25 | -1.23 | -0.8 |
| 7 Days Ago | -0.13 | 0.1 | -0.92 | 0.48 |
| 30 Days Ago | -0.13 | 0.1 | -0.92 | 0.48 |
| 60 Days Ago | -0.13 | 0.1 | -0.92 | 0.48 |
| 90 Days Ago | -0.13 | 0.1 | -0.92 | 0.48 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| PRPH | 52.94% | -257.14% | -25.51% | 34.96% |
| S&P 500 | 8.58% | 11.41% | 13.97% | 13.43% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 2/21/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 11/10/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/14/2023 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 6/2/2023 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/12/2023 |
| Reiterates | HC Wainwright & Co.: Buy | 3/8/2023 |
Related Tickers
APDN Applied DNA Sciences, Inc.
0.1934
-2.18%
ENZ Enzo Biochem, Inc.
0.6643
-2.31%
STIM Neuronetics, Inc.
2.3400
+36.84%
VNRX VolitionRx Limited
0.6210
-4.75%
BIAF bioAffinity Technologies, Inc.
0.7547
-6.83%
MYNZ Mainz Biomed N.V.
4.6700
+9.11%
EZB.BE Enzo Biochem Inc
0.6300
-2.33%
NN6.F NanoRepro AG
1.4200
-4.05%
IDHCl.XC
ESF0.MU Eurofins Scientific SE
50.22
0.00%